RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. 2008

Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
Department of Medical Microbiology, Immunology, and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois 62702, USA.

RhoC is a member of the Ras-homologous family of genes which have been implicated in tumorigenesis and tumor progression. However, the exact role of RhoC is controversial and is yet to be clarified. We have examined the effect of RhoC on prostate tumor cells and found that RhoC had no effect on cell proliferation in vitro or on tumor growth in mice. However, RhoC significantly enhanced the metastatic ability of the tumor cells in these animals, suggesting that RhoC affects only the metastasis but not the growth of prostate tumor cells. The results of our immunohistochemical analyses on tumor specimens from 63 patients with prostate cancer indicate that RhoC expression had no significant correlation with Gleason grade. However, the expression of RhoC showed significant positive correlation with both lymph node and distant metastasis, and it was inversely correlated with patient survival. We also found that RhoC significantly augmented the invasion and motility of prostate tumor cells by activating matrix metalloproteinases 2 and 9 (MMP2 and MMP9) in vitro. The results of our antibody array analysis for signal molecules revealed that RhoC significantly activated kinases including mitogen-activated protein kinase (MAPK), focal adhesion kinase (FAK), Akt, and Pyk2. Inhibition of Pyk2 kinase blocked the RhoC-dependent activation of FAK, MAPK, and Akt, followed by the suppression of MMP2 and MMP9. Inhibitors of both MAPK and Akt also significantly blocked the activities of these MMPs. Therefore, our results indicate that RhoC promotes tumor metastasis in prostate cancer by sequential activation of Pyk2, FAK, MAPK, and Akt followed by the up-regulation of MMP2 and MMP9, which results in the stimulation of invasiveness of tumor cells.

UI MeSH Term Description Entries
D008297 Male Males
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075024 rhoC GTP-Binding Protein A rho GTP-binding protein that is prenylated (see PROTEIN PRENYLATION) at its C-terminus and cycles between the cytoplasm and plasma membrane, linking receptor signaling pathways with assembly of FOCAL ADHESIONS; STRESS FIBERS; and contractile ring formation during CYTOKINESIS. It is overexpressed in proliferating and metastatic tumor cells. ras Homolog Family Member C,rhoC GTPase,GTP-Binding Protein, rhoC,rhoC GTP Binding Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
January 2011, The Journal of biological chemistry,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
November 2007, Molecular and cellular biology,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
December 2017, Oncotarget,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
January 2019, American journal of translational research,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
November 2016, European review for medical and pharmacological sciences,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
January 2017, PeerJ,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
June 2009, Cancer research,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
July 2016, International journal of oncology,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
May 2016, Cellular signalling,
Megumi Iiizumi, and Sucharita Bandyopadhyay, and Sudha K Pai, and Misako Watabe, and Shigeru Hirota, and Sadahiro Hosobe, and Taisei Tsukada, and Kunio Miura, and Ken Saito, and Eiji Furuta, and Wen Liu, and Fei Xing, and Hiroshi Okuda, and Aya Kobayashi, and Kounosuke Watabe
October 2021, FEBS open bio,
Copied contents to your clipboard!